Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Pharmacokinetic Profile and Pharmacodynamic Characteristics of a Furosemide High Dosage Formulation in Patients With Chronic Renal Failure Undergoing Peritoneal Dialysis [Phase 1]
This Phase 1 study reports the pharmacokinetic and pharmacodynamic characteristics of a high-dose furosemide formulation in patients with ch…
-
CLINICAL_TRIALS withdrawal · 2013-02-08Clinical Trial Update: Comparison of a Non-Invasive Central Venous Pressure Device and Physical Examination in Patients With Chronic Kidney Disease
A clinical trial comparing a non-invasive central venous pressure device to physical examination in patients with chronic kidney disease has…
-
CLINICAL_TRIALS trial_result · 2013-02-07Clinical Trial Update: Efficacy and Safety of Sugammadex in Renal Diseased Patients [Phase 4]
A Phase 4 trial evaluated the efficacy and safety of sugammadex in patients with chronic kidney disease undergoing reversal of neuromuscular…
-
FDA approval · 2013-02-07FDA Approved: CALCIUM ACETATE — Original Application (Cipla USA Inc.,)
The FDA approved Cipla USA Inc.'s original application for Calcium Acetate (generic calcium acetate).
-
FDA approval · 2013-02-05FDA Approved: CALCIUM ACETATE — Original Application (Chartwell RX LLC)
FDA approves Chartwell RX LLC's calcium acetate as a new generic phosphate binder under an Original Application (ANDA 202420).
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-05Clinical Trial Update: Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure [Phase 1]
A Phase 1 study evaluating combined bone marrow and kidney transplantation for patients with multiple myeloma and chronic kidney disease has…
-
FDA approval · 2013-02-01FDA Approved: FERRLECIT — Supplemental Application (sanofi-aventis U.S. LLC)
The FDA approved a supplemental application for Ferrlecit (sodium ferric gluconate complex) submitted by Sanofi-Aventis U.S. LLC.
-
FDA approval · 2013-01-30FDA Approved: DELFLEX — Supplemental Application (Fresenius Medical Care de Mexico, S.A. de C.V.)
FDA approved a supplemental application for DELFLEX, a dialysis solution from Fresenius Medical Care de Mexico, S.A. de C.V.
-
CLINICAL_TRIALS trial_result · 2013-01-15Clinical Trial Update: Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease [Phase 2]
Phase 2 randomized trial comparing xiEnce and visioN coronary stents in patients with chronic kidney disease and multivessel coronary artery…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Saving Residual Renal Function Among Haemodialysis Patients Receiving Irbesartan [Phase 3]
This Phase 3 trial update examines whether irbesartan can preserve residual renal function in adults with chronic kidney disease on haemodia…
-
CLINICAL_TRIALS trial_result · 2013-01-08Clinical Trial Update: Study of the Effect of Synchronised Anaemia Management in Chronic Kidney Disease [Phase 4]
A Phase 4 clinical trial evaluating synchronised anaemia management in patients with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Peginesatide for Anemia in Chronic Hemodialysis Patients [Phase 2]
The document reports the completion of a Phase 2 trial evaluating peginesatide for anemia in chronic hemodialysis patients with chronic kidn…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Safety, PD & PK of Multiple Doses of Peginesatide for Anemia in Chronic Kidney Disease Patients [Phase 2]
Phase 2 study evaluating safety, pharmacodynamics, and pharmacokinetics of multiple peginesatide doses for anemia in chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Observational Study to Evaluate the Time to Achieving the Maintenance Dose of Zemplar® (Paricalcitol Injection) in the Treatment of Patients Suffering From End-stage Renal Disease and Severe Over-reactivity of the Parathyroid Glands
This completed observational study evaluated the time to achieve the maintenance dose of paricalcitol (Zemplar) in patients with end-stage r…
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Safety of Single Doses of Peginesatide in Patients With Chronic Kidney Disease [Phase 2]
This Phase 2 trial assessed the safety of single-dose peginesatide in patients with chronic kidney disease. The study was terminated.
-
CLINICAL_TRIALS trial_result · 2012-12-21Clinical Trial Update: Safety and Pharmacokinetics of Single Intravenous Doses of Peginesatide in Healthy Volunteers [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of single intravenous doses of peginesatide in healthy volunteers.
-
CLINICAL_TRIALS trial_result · 2012-12-06Clinical Trial Update: Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism [NA]
A completed clinical trial comparing paricalcitol versus calcitriol for safety and efficacy in treating secondary hyperparathyroidism in pat…
-
CLINICAL_TRIALS trial_result · 2012-12-05Clinical Trial Update: Analysis of Calcium Balance in Chronic Kidney Disease [NA]
This document reports the completion of a clinical trial analyzing calcium balance in chronic kidney disease, with the study sponsored by th…
-
CLINICAL_TRIALS research · 2012-12-03Clinical Trial Update: Renal Sympathetic Denervation in Patients With Chronic Kidney Disease and Resistant Hypertension [NA]
A clinical trial update indicating ongoing study of renal sympathetic denervation in patients with chronic kidney disease and resistant hype…
-
CLINICAL_TRIALS trial_result · 2012-11-28Clinical Trial Update: Role of Prohepcidin in Uremic Patients
Completed clinical trial evaluating prohepcidin in uremic patients; conditions include inflammation and chronic kidney disease.
-
CLINICAL_TRIALS trial_result · 2012-11-21Clinical Trial Update: Arterial Wall Calcium Load in Pseudoxanthoma Elasticum
A clinical trial update evaluating arterial wall calcium load in Pseudoxanthoma Elasticum, with co-occurring Type 2 diabetes mellitus and ch…
-
CLINICAL_TRIALS trial_result · 2012-11-14Clinical Trial Update: A Study in Children With Growth Failure Due to Chronic Renal Insufficiency (CRI) or End Stage Renal Disease (ESRD)
A completed clinical trial sponsored by Genentech investigating growth failure in children with chronic kidney disease and end-stage renal d…
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Treatment of Early Stage Renal Failure With Active Vitamin D or a Phosphate Binder. [Phase 2]
Phase 2 clinical trial evaluating active vitamin D versus a phosphate binder for early-stage renal failure has been completed.
-
CLINICAL_TRIALS trial_result · 2012-11-09Clinical Trial Update: Effect of Obesity on Long-term Clinical Outcomes After Kidney Donation
Completed clinical trial evaluating the impact of obesity on long-term outcomes after kidney donation.
-
CLINICAL_TRIALS trial_result · 2012-11-08Clinical Trial Update: Open-label Pharmacokinetic Study of Iron Isomaltoside 1000 (Monofer®) Administered as Single Bolus Injections in Subjects With Stage 5 Chronic Kidney Disease on Dialysis Therapy (CKD-5D) [Phase 1]
Phase 1 open-label pharmacokinetic trial of iron isomaltoside 1000 (Monofer) given as a single bolus in adults with stage 5 chronic kidney d…